Product News

Share this article:

Wyeth received FDA approval for a new indication on Tygacil, a pneumonia drug. The additional indication was approved for adult patients with community-acquired bacterial pneumonia.

 

A New York federal judge has asked the FDA to make Plan B, an emergency contraceptive, available to 17-year-olds within 30 days. US District Judge Edward Korman also asked the agency to review whether to make the product available for girls of all ages, without a prescription. Plan B is manufactured by Barr Pharmaceuticals, a division of Teva Pharmaceuticals.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.